They say Spring is the season of change, and that surely has been the case here at Altasciences! Let me start with our successful implementation of the eTMF Connect platform (Montrium’s eTMF solution). Moving from a paper-based TMF process into an electronic system allows Altasciences’ teams to benefit from real-time reporting features using the eTMF Navigator dashboard. Externally, sponsors have the same real-time access to their documentation allowing direct oversight of the TMF without the need for manual requests. In addition, we recently completed the expansion of our purpose-built inhalation testing facilities across our clinical research units in North America. This expansion cements our commitment to sponsors in helping them meet the requirements for regulatory submission for inhalation products. It also makes us uniquely qualified to conduct certain types of specialized smoking/vaping trials for the evaluation of tobacco, cannabis, and electronic nicotine delivery systems (ENDS). And finally, we are very excited with our recent partnership with WuXi AppTec, where we will provide full-service support and conduct comprehensive early phase clinical services for their multiple ongoing WIND programs. These are just some of the recent events contributing to Altasciences’ growth and keeping us at the forefront of the industry. I look forward to sharing many more exciting developments with you in the coming months. MESSAGE FROM OUR CEO Chris Perkin, Chief Executive Officer, Altasciences